Summit Biosciences
2009
FOUNDED
PRIVATE
STATUS
21-30
EMPLOYEES
Early Stage VC
LATEST DEAL TYPE
$350K
LATEST DEAL AMOUNT
2
INVESTORS
Description
Provider of specialized pharmaceutical products intended to focus on developing, manufacturing and commercializing generic and innovative nasal spray medicines. The company's pharmaceutical products offer commercial production of unit-dose, nasal spray products with development and production of pre-filled, disposable, intranasal spray products, enabling clients to address and meet important needs for the management of chronic and acute care conditions.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
- UK Coldstream Research Campus
- 1513 Bull Lea Road
- Lexington, KY 40511
- United States
+1 (859) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Summit Biosciences’s full profile, request a free trial.
Summit Biosciences Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | $350K | 00000 | Completed | Generating Revenue | ||
| 1. Debt - General | 10-Sep-2014 | Completed | Generating Revenue |
Summit Biosciences Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Startups@KSTC | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Yearling Management | Venture Capital | Minority | 000 0000 | 000000 0 |
Summit Biosciences Executive Team (5)
1 Former Executive
You’re viewing 4 of 5 executives. Get the full list »Summit Biosciences Board Members (5)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Edwin Cohen | Summit Biosciences | Founder, Chief Executive Officer & Chairman of the Board | 000 0000 | |
| R. Charles Moyer Ph.D | Self | Board Member | 000 0000 | |
| Richard Cohen | Self | Board Member | 000 0000 | |
| Robert Saunders Ph.D | Self | Board Observer | 000 0000 | |
| William Lomicka | Yearling Management | Board Member | 000 0000 |